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Immunization against hepatitis A is now recommended by the World 
Health Organization in subjects at risk of exposure to HAS? 
The aim of this study is to show that the acute madestations 
of HAV infection can be severe with prolonged clinical course and 
relapsing forms. 
476 patients with AVH were treated in the Infectious Diseases 
Hospital during 1995 last year. 305 /64.08%/ were with AVH A. 
Clinical signs and symptoms, liver &orders, biochemical mark- 
erdbilirubin, ASAT, ALAT, akphosphatase, B-lipoproteins, fibrino- 
genlwere analysed in 68 patients, aged 4C-71 years presenting seri- 
ous and long course of the disease with hgh  levels of bllirubinaemia 
1126-428 mkmol/l, /and serum increased transaminases activities 
/ASAT 224818 UIA, ALAT 402-1179 UI/l. Signs of cholestasis 
were in 48.52%, acute cholecystitis and cholangitis in 8 p. Fulm- 
nant form with encephalopathy developed in one 44 years old man, 
in contact with his child with AVH A. The patients were treated 
from 20 to 37 days in the hospital. Normalising of the biochemical 
changes at the time of &charge was in 70%. One month later ab- 
normal ASAT and ALAT levels were found in 11 patients. Relapse 
was in 3 patients with alcohol abuse. 
Conclusion: The acute HAV mfection is severe in adults and 
complications may develop. 
HAV RNA replication and polyprotein processing have not been 
demonstrated in infected cells. 
Methods: Using the fast growing HAVstrain HAS-15 short term 
kinetics were performed for the analysis of RNA and protein synthe- 
sis. An ELISA against viral capsids was undertaken and polyprotein 
processing was investigated by immunoblot using specific rabbit or 
guinea pig antisera. Synthesis of viral minus- and plus-strand FWA 
was followed by RT-PCR using primers of the 5' noncoding region 
of the genome. 
Results: Via ELISA viral antigen was detected starting 48 h after 
infection. Simultaneously with the appearance of viral capsids the 
viral proteinase 3C was detected together with the individual capsid 
proteins WO, VP1 and W3. Precursors of structural and functional 
proteins were found subsequently. Plus-strand RNA synthesis ap- 
peared 6 h after mfection, minus-strand RNA appeared 2 h later. 
During the first days of infection plus-strand RNA was found in a 
100 fold higher concentration than minus-strand RNA. 
Conclusions: From our results we conclude that RNA synthesis 
starts early on after infection although HAV grows slowly in cell 
culture. Polyprotein processing seems to be initiated by viral pro- 
teinase 3C which is detected prior to its precursors and those of the 
structural proteins. 
I P961 I Prediction of Hepatitis A Morbidity and 
Quantitative Evaluation of 
Enzymoimmunoassay's Results 
D.E. Toropov, PI. Ogarkov, A.R. Volgm, VS. Tokmakov. 
Military-Medical Academy, Saint-Petusburg, Russia 
In 19961995 the Diagnostic Center in Samara performed enzy- 
moimmunoassay in 2139 patients with hepatits A (HA) using di- 
agnostic preparations and equipment made by Roche Diagnostic 
(Switzerland). Anti-HAVIgh4 titers in blood serum were quantita- 
tively evaluated by the value of the ratio between sample optical 
density (OD) and cut-off level. 
Comparison of mean OD values per month with monthly dy- 
namics in HA morbidity revealed a relatively low correlation ratio 
for an epidemic year in general (r = 0.46). Yet OD values were min- 
imal in July when morbimty rates were at the lowest, while increase 
waves in August and October 1995 coincided on both plots. Lower 
OD values in September and October corresponded to stabilization 
of the number of the patients idenhfied during these months. Hence 
from July to November, i.e. during season rise, a strong correlation (r 
= 0.74) was revealed between monthly values of HA morbidity and 
anti-HAVIgM titers in patients blood sera. However, a continually 
increasing morbidity in December was accompanied by a decrease 
in mean values of OD samples relative to cut off level. 
Thus starting h m  November, OD values indirectly reflecting 
patients responses to HAV invasion cease to follow morbidity dy- 
namics which may be regarded as a decrease in the agent's virulence 
even before season morbimty peak. This is a favourable predicting 
circumstance, permitting the use of anti-HAVIgM titer variations 
in quantitative evaluation of EIA results for prompt epidemiologic 
analysis. 
RNA Replication and Polyprotein Processing of 
Hepatitis A Virus (HAV) in FRhM Cells 
R. b e r e r ,  B. Hornei, C. Probst, V. Gauss-Miiller. Institute of 
Medical Microbiology and Hygiene, Medical University of Ldbeck, Ldbeck, 
Germany 
Objectives: Hepatitis A virus is an atypical picornavirus causing 
considerable morbidity in adults. Due to the virus' slow p w t h  
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Prevalence for Hepatitis B and C in Sexually 
Active Men by Unlinked Anonymous Testing 
(UAT) of Condom Semen Samples 
P Vernazza, L.A. Pfister, W Fierz, J. Osterwalder. Kantonsspital and 
I kMI ,  St. Gallen, Switzerland 
Objective: To evaluate the use of condom semen sample for sero- 
logic monitoring for Hepatitis B and Hepatitis C by UAT in order 
to extend our previously reported findings on UAT for HIV with 
this procedure 
Methods: Seminal plasma was obtained h m  condoms used by 
prostitutes in eastern Switzerland. Sensitivity and specificity of com- 
mercially available serologic tests for HBV and HCV in seminal 
plasma were established with semen samples h m  subjects with 
known blood serology. A total of 804 condom semen samples were 
available for testing 
Results: Sensitivity of the serologic tests applied was 75% for 
HBV (antiHB, I&, Axsym Core, Abbott), and 87% for HCV 
(Axsym HCV, Abbott). The spenficity of both assays in seminal 
plasma was 100%. Results of the condom semen sample testing are 
given in the table. 
Anubody Test N tested N positive Prevalence 95% CI 
and-HB,-IgG 749 21 2.8% 154.6% 
ma-HIV 804 0 0% a-o.54% 
ano-HCV-IgG 559 8 1.4% 0.5-3.0% 
Conclusion: The method of UAT of condom semen samples is 
applicable for the epidemiologic monitoring of the prevalence of 
Hepatitis B and C. Given the low sensitivity of the method (which 
is object to further improvements) the results underestimate the true 
prevalence. 
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I P964 I Some Laboratory and Morphologic Changes in 
HBV/HCV Asymptomatic Infection 
K. Zhdanov, Y. Lobzin, S .  Mukomolov, V. Chirsky. Military Medicnl 
Academy, St. Petenbuv, Russia 
Objectives: Determination of clinical and histologic features of 
asymptomatic B, C hepatitis. 
Methods: 66 blood donors (age 18-20 years) with HBsAg (32) 
and anti-HCV (34) asymptomatic infection have been studied at 
the special &tic. Clinical, biochemical, serologic methods and liver 
biopsy have been used. 
Results:T> Hepatomegaly (62%) and splenomegaly (15%) have 
been determined. 48% patients had increased levels of serum ALT. 
Serologic data demonstrated the presence of HBeAg (29%), HBV 
DNA (76%), anti-HCV IgM (33%), HCV RNA (78%). Liver biopsy 
results showed chronic hepatitis with minimum and mild activity of 
pathological process in 82% of cases. 
Conc1usions:The determined markers and histologic changes in 
HBV/HCV infected persons rweal high activity of the virus even in 
the absence of &cal evidence of the &ease. This is important for 
the early antiviral therapy and prognosis. 
lp965) Acute HBV Infection in Patients with Chronic 
D. Stankovi&Djordjevii. Public Health Center ofNif,  Yugoslavin 
The examination included 15 patienk with chronic HCV infection 
@stologicaly verified, anti HCV IgG, ELISA I1 gen. and RIBA 
I1 gen. reactive) and acute HBV superinfection. the patienk 
(previously symptom-he, without remarkable physical signs, with 
elevated serum ALT and without HBV markers) suffered h m  gen- 
eral symptoms of acute hepatitis with icterus and increase of ALT 
level. At that time 12 (80%) patients had a serological status of HBV 
replication (Hbs, Hbe, anti Hbc IgM positive). However, in 3 (20%) 
patienk serological course of acute HBV infection was unusual. One 
patient had no detectable level of Hbs antigen. In 2 patienk extinc- 
tion of serum Hbs Ag was near the cutoff value. These 3 paaenk 
had detectable level of anti Hbc IgM and the level of Hbc IgG was 
in increase. All of them had anti HCV IgM as a marker of active 
HCV replication. The observations suggesk that HCV may exert a 
suppressive effect on HBY 
HCV Infection 
189661 HBV Markers among Anti HCV Positive 
V Grunevska, Lj. Ivanovski, D. Dimitriev, S. Sami, C. Nasteska, 
M. Gaseva. Clinic ofhjctiow Diceam and Febrile States, "St. Cyril 
and Methodius" University, Skopje, Republic of Mmdonia 
Objectives: To investigate HBV infection in haemodialysis patienk 
with anti HCV positive results because of the same mode of trans- 
mission. 
Material and Methods: Ths  is a prospective study including 
anti HCV positive patients on haemodialysis. They were grouped by 
sex, age and duration of haemodialysis. Testing was made in 1995 at 
our Clinic. The investigation was made for HCV using ELISA kik 
(ORTHO HCV 3.0 ELISA) and results were confirmed with Im- 
munoblot Assay (Chiron RIBA HCV 3.0 Strip Immunoblot Assay). 
HBV markers ( H B s A g ,  anti HBs and HBcIgG) were identifed using 
Behring ELISA kits on Behring Processor. 
Results: Tested were 46 anti HCV positive haemodialysis patients. 
4 (8.7%) of them were HBsAg, 17 (37.0%) anti H B s ,  13 (28.3%) 
B c I &  positive (making a total of 34 (74%) positive HBcIgG cases), 
and 12 (26.0%) without HBV markers. HBsAgpositive patients were 
Haemodialysis Patients 
tested for HBeAg and anti HBe: 1 was HBeAg positive, and 1 anti 
HBe positive. 
Conclusions: Transmission of the virus among our haemodialysis 
patients is intensive compared to that in the general population, 
where the prevalence is 1.55%. Out of 46 anti HCV positive cases, 
34 (74%) had verified present or past HBV infection, in spite of 
their ordinary control and obligated testmg of blood donors for 
HBsAg. 12 (26.0%) were without HBV markers but, considering 
their positive anti HCV status and the same mode of nansmission of 
both viruses, it is possible that they could be infected later. So, besides 
caution for HCV, we have to take care of HBV as a cause of liver 
damage among these patienk with ik c h c d  and epidemiological 
consequences. This imposes their active HBV immunization which 
would prevent this population h m  HDV as well. 
1 P967 1 Hepatitis B Precore/Core Sequences in 
Romanian Children with Chronic Hepatitis 
infection 
L.S. Iancu', R .  Ling2, E. Moraru', S .  Gotia', T.J. Harrison*. 
' University of Medicine and Pharmacy, h i ,  Romania, 'The Royal Free 
Hospital School $Medicine, London, UK 
Objectives: To investigate the p d e n c e  and clinical implication of 
infection with hepatitis B virus (HEW) pre-core mutant. 
Methods: The antigens and antibody markers for HBV infection 
were investigated by ELISA. A region of HBV/DNA corresponding 
to the precore and beginning of the core gene coding sequences was 
ampwied using nested PCR. The produck were cloned using the 
TA cloning system (Invitrogen) and sequenced using the -40 and 
reverse primers and Sequenase V 2.0 (Arnersham). 
Results: Four of 10 HBsAg positive children were positive for 
HBV/DNA. Two of these had a wild type virus sequence in the 
region amplified (nudeotide-1795 to 2133) whilst another &om an 
HBeAg negative child with chronic active hepatitis (CAH) was a 
precore mutant with G to A substitution at nucleotide 1896 (result- 
ing in TAG stop codon). The fourth HBV precore/core sequence 
h m  a six yeat old boy with CAH and negative for HBeAg was 
infected had a mutation at nudeotide 1938 (T to A point mutation 
corresponding to an unusual d i n e  to glutamate change) and others 
at nucleotides 1961, 1966 and 1969 causing unusual although more 
conservative changes of serine to proline, aspartate to glutamate and 
phenylalanine to leucine respectively). 
Conclusions: (1) An unusual core gene sequence has been iden- 
tified that may lack HBeAg reactivity. (2) These mutations seems 
sunilar in &cal consequences with the mutation from 1896 nu- 
cleotide, but other observation are required for a complete case de- 
scription and to establish ifthe observed changes abolish the HBeAg 
reactivity. 
Hepatitis B WNS Subtypes Distribution in 
Families with Two or More Members HBsAg+ 
A. Delgado-Iribarren, A. Perez, M. del h o ,  A. Arribi, 
T. Caiiedo, L. Guerra. Hospital Sever0 Ochoa, Legad,  Madrid, Spain 
The Geographic situation of Spain gives a particular distribution 
of Hepatitis B virus subtypes intermediate between North-Europe, 
with a ad subtype predominance, and North-Afkca and Mediter- 
ranean area with an ay subtype predominance. 
Objective: To scudy i n t r a f d a r  distribution of HBV subtypes 
in HBsAg+ members from the same famdy in Spain. 
Methods: 84 people HBsAg+ belongmg to 30 farmles from 
FuenIabmda-Leganes, Madrid, Spain were tested 30 index cases 
(IC), 11 brothers, 10 sisters, 4 fathers, 5 mothers, 2 husbands, 3 
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wives, 17 sons, 6 daughters and 2 nephews of IC. We have applied 
an ELISA method with specific monoclonal antibodies to subtype ad 
and to group determinant a for subtyping the virus. All the reagents 
and controls were gently provided by Murex Diagnostics. 
Results: 36.9% were ascribed to ad subtype and 63.1% to ay 
subtype. Family members showed the same subtype in all but one 
f d e s  studied in 13 cases subtype ad and in 16 cases subtype 
ay. The remaining case was a mother and two sons showing an ay 
subtype, meanwhile the father was ascribed to ad subtype. 
Conclusion: HBV subtyping may be an easy epidemiological 
tool with which we have demonstrated the importance of innafa- 
miliar transmission of HBV. 
lntrafamilial Clustering of Hepatitis B Virus 
(HBV) in Spain 
A. Delgado-Iribarren. A. Ptrez, M. del b o ,  A. Arribi, 
T. Caiiedo, L. Guerra. Hospital Sever0 Ochoa, Legan&, Madrid, Spain 
Objective: To study HBV infection in families of patients HBsAG+ 
and possible transmission routes. 
Methods: We have studied to 1475 relatives of 449 index cases, 
42 acute hepatitis and 407 chronic carriers (37 HBeAg+ and 361 
HBeAb+) from Fuenlabrada-Legan&, Madrid, Spain. Relationship 
with the IC was: 231 parents, 316 husbanddwives, 540 children, 
251 siblings and 137 other people living together with I.C. 
Results: Overall prevalence for HBsAg was 7% (95% C.I. 
5.96-8.44%) and 3.07% for HBcAb (95% C.I. 28.38-33.15%). The 
following markers and chronicity rates (C.R. = HBsAg+/HBcAb+ 
x 100) were obtained in the group: 
HBsAG+ HEIcAB+ C.R.% 
Fathers 4.7 52.8 8.9 
Mothcn 14.4 36 25.7 
Husband/Wife 2.8 34.8 8.1 
Children 5.9 15.4 32.5 
Sibhng 16.7 46.4 36.2 
Others 1.4 13.1 11.1 
Conclusion: Sigdicant hgher prevalence of infection in fami- 
lies of patients HBsAG+ (reported rates in general population from 
our community: 1-1.5% HBsAG+, 18-20% HBcAB). High preva- 
lence of HBsAG and C.R. in mothers, siblings and children possibly 
reflects the importance of vertical transmission. 
1 P970 I Detection of Hepatitis B Virus (HBV) DNA by 
PCR in HBsAg Negative Relatives of HBsAg 
Chronic Carriers in Spain 
A. Delgado-Iribarren, A. Perez, M. del Alamo, A. Arribi, 
T. Caiiedo, L. Guerra. Hospital Sever0 Ochoa, Legan&, Madrid, Spain 
Objective: To detect silent carriers of HBV in relatives of HbsAg 
chronic carriers (CC) which present HbcAb as only marker. 
Methods: 58 out of 1475 studied relatives of 449 CC which 
present HBcAb as only marker were investigated for presence of 
HBV DNA in sera by PCR using primers of the core region. Con- 
trol sera of patients with HBV DNA+ by hibridization methods 
were used. One to three vaccine doses were given to every patient 
in order to detect HBsAb production. We considered response to 
one dose titles over 300 UI/l (as a booster reaction) and to three 
doses more than 10 UI/L. 
Results: 32.7% patients responded to one vaccine dose and 43.1% 
to three vaccine doses. We could not detect HBV DNA in any 
patient with HBcAb as only marker. 
Conclusions: Silent carriers of HBV are infcecuent in our coun- 
try even in risk groups. F& of HBsAg CC with HBcAb alone 
present a high rate of vaccine response although their infection risk 
is unknown without vaccination. 
m1 infection with Hepatitis Viruses at Patiens with 
I. Rebedea, I. Strauss, EA. CIruntu, A.M. Tudor, N. Stemate. 
Clinical Hospital Colenfina Bucharest, Romania 
Objectives: The aim of the s t u d y  was to appreciate the risk of the 
comfection with hepatitis viruses at the patients with HIV infection. 
Methods: It was pe6ormed a multiple screening for hepatitis 
viruses A, B, D and C at 1204 patients with HIV/AIDS 
Results: There were 138 chaildren infected with hepatitis B virus 
(HBV) from 1110 chlldren with HIV/AIDS and 13 adult patients 
infected with HBV h m  94 adult patients with HIV/AIDS. 
Most of the adult patients diagnosed with coinfection HIV-HBV 
were young, 8 of them were under 40 years old. Comfection 
HIV-HBV afiected more fkquently children over 4 years old, 134 
from 138 patients. There were also founded one patient with coin- 
fection HIV-VHB-HDV and two patients with HIV-HAV coinfec- 
tion. 
The stages of hepatic dueases were: chronic carrier of AgHBs - 11 
adults and 84 children, chronic hepatitis B -2 adults and 51 children. 
There were three children with chronic hepatitis B + D and five 
children with chronic hepatitis C. 
Conclusions: The high fkquency of HBV at HIV infected pa- 
tients can be explaned by the same route of transmission and the 
high prevalence of HBV infection in our country. The long term 
prognosis of this patients is worsened by this coinfection. 
HIVIAIDS 
An Analysis of Reasons for an Increase of 
Hepatitis B Morbidity in Samara Region 
D.E. Toropov, PI. Ogarkov, L.V. Beliaeva, V.S. Tokmakov. 
Military-Medical Academy, Saint-Petenburg, Rmsia 
In 1994-1995, anti-HAVIgh4, HBsAg, HBeAg, anti-HBs, anti-Hbe, 
anti-HBcIgM, anti-HCV markers were detemined in blood sera of 
4869 patients in Samara Region by the enzymoimmunoassay (EIA) 
using diagnostic preparations and equipment made by Roche Diag- 
nostic (Switzerland) and Sanofi Diagnostics Pasteur (France). 
Until 1992, hepatitis B (HB) morbidity rates in Samara Re- 
gion population had not Mered essendy from those registered 
throughout the Russian Federation. Since 1993, however, this 
mid-Volga region has been rankmg among the three most HB af- 
fected of 89 territories under the RF jurisdiction. While HBsAg car- 
riage rate was under 1%. HB morbidity reached 83.14 per 100.000 in 
1995. Along with improved laboratory diagnostic techiques includ- 
ing the use of EIA, The increase of morbidity u*as associated with 
involvement of young adults in the epidemic process. The hghest 
HB affection has been recorded in males aged from 15 to 19 years 
and h m  20 to 24 years. Similar results were obtained while exam- 
ing HC patients: males had HC 2.2-2.4 times more fkquent than 
females, and the most affected group comprised persons of 15 to 19 
year old, with males at this age range being HCV infected by 4.6 
times more often than girls. 
Thus, the rise of HB morbidity in Samara Region is associated 
with involvement in the epidemic process predominantly of young 
males. The risk group of manifest HA includes persons with HBV- 
and HCV-induced liver lesions. 
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wl Hepatitis and Retmviral Infections in 
Repartiated Greek Children 
C. Politis 
E. Georgakopoulou ', E Gounari ' . 'Hellenic Red Cmss Blood Center, 
Athens, Greece, 'National School ojPublic Health, Athens, Greece 
Objectives: To define the prevalence of hepatitis B-E markers and 
retroviral infections in children and their families of repatriated 
Greeks who where living in underdeveloped areas. 
Materials and Methods: We screened 378 children aged 8-12 
years from two schools outside Athens where repatriated Greeks 
from es-USSR live. The examinations for hepatitis B E  markers and 
HIV and HTLV infections were performed by the use of Elisa tests 
and Kiba 111. 
The families of seropositive chlldren were also examined and vac- 
cination against HBV with r-DNA Hepatitis B (Engerix, Smithkline 
Beecham) was performed in the susceptible persons. Appropriate 
councelling was provided to the families throughout the study. 
Results: The prevalence of HBV and HCV in the children of 
the study is very hgb  in comparison to the native Greek popula- 
tion. HEkAg 6.6% anti-Hbcore 6.5% anti-HCV 1.3%. No positivity 
was detected for anti-HEV, anti-HIV and anti-HTLV. Intrafamiliar 
uansmission of HBV is 34% and of anti-HCV 8%. Ninety percent 
of the sensitiw persons accepted vaccination against HBV without 
any adverse reactions. The immunological response was successful in 
all subjects. 
Conclusions: Preventive measures for the dispersion of hepatitis 
B and other mfections b o r n  immigrants coming to Greece from 
countries with Merent epidemiological status are necessary. 
J. Kourea-Kremastinou *, S. Fragatou ' , E. Kapsali ', 
Prevalence of Viral Markers to Hepatitis B, C and 
Delta Vituses in Patients with Hepatocellular 
Carcinoma (HCC) in Egyptians 
Hassan Rizk', A. El-Kholly', H. Nagieb '. 'Department 4Znfernaf 
and Tropical Medicine, Mansoura Univmsify, E m f ,  'Department .f 
BiochemisQ, Mansoura University, E m f ,  'Deparfment ofkficrobiology, 
Mansoura University, E n p t  
Studies had confirmed the strong association that exist between 
chronic H B Y  H C V  mfections and the occurrence of primary liver 
tumours. In Egypt H C Y  HBV and H D V  are common. The aim 
of this work was to study the relative prevalence and importance of 
these 3 viruses in the pathogenesis 0fH.C.C. in Egyptians. The study 
comprised 98 cases (83 males and 15 females) with primary liver can- 
cer diagnosed hca l ly ,  sonographically, and by liver biopsy. Alpha 
feto-protein was 5-100 mg/d  in 22% of cases, 100-500 mg/d in 
58% and more than 500 mg/d  in 19%. Child-Bugh classification, 
19% class A, 52% dass B and 33% ckss' C. Okuda staging, 12% 
stage (I), 66% of cases stage (II), 21% stage 011). HBVmarkers were 
determined by FUBA. Anti-HCV was detected by second genera- 
tion ELISA and PCR. Delta IgM and anti-HDV by Delta k was also 
done. It was found that 83% of cases were anti HCV positive. HBsAg 
was detected in 7%. Co-infection by HBVand H C V h a s  been found 
in 3%. Anti HDV was positive in 5% but in younger age group. All 
cases had cirrhosis and elevated liver enzymes more with anti-HCV 
positive cases. In conclusion cirrhosis is present in all patients in all 
virus related HCC, also young male carrier of HBs Ag, productive 
H B V  and H D V  mfections induce an early development of cirrhosis 
and represent the highest risk for HCC. This stresses the importance 
of effective anti-viral treatment and programs of HBV vaccination 
and with development of HCV vaccination and early treatment of 
young HBsAg carriers to decrease the incidence of H.C.C. 
Incidence of Acute Viral Hepatitis in Belgium 
R. Vranckx, D. Devroey, V. Van Casteren. lncfitute ofHygiene and 
Epidemioloa, Bmssek, Belgium 
Objectives: After an initial inventory in 1982, the sentinel gen- 
eral practitioners made a record in 1991 and 1992 of all patients 
susceptible to having acute viral hepatitis. 
Materials and Methods: The data of this study was recorded by 
124 general practitioners. The doctors were distributed in a homoge- 
neous way throughout Belgmm and covered an  estimated population 
of 150,000 inhabitants. The patients were recorded on the basis of 
clinical suspicion of acute viral hepatitis. The HAV antibodies, HBV 
antigens and antibodies, HCV antibodies and HEV antibodies were 
determined by commercial RIA or EIA tests. 
Results: During the two years, 209 patients susceptible to having 
acute viral hepatitis, diagnosed on the basis of clinical signs, were 
recorded. 67.2% of the patients were positive for hepatitis A, 18.0% 
were positive for hepatitis B, 9.9% were positive for hepatitis C and 
1.6% were positive for hepatitis E. 3.3% of the patients, both I.V. 
drug abusers, were positive for hepatitis B and hepatitis C. 
Discussion: The incidence of acute Wa hepatitis recorded by the 
sentinel practitioners was significantly lower in 1991-92 compared 
to 1982. Only about 12% of the cases recorded in this study were 
declared in the obligatory declaration system. 
w\ The Epidemiological and Clinical Features of 
Viral Hepatitis in Pdsoners of Russian 
Federation (Preliminary Results) 
E. Savin l ,  V. Sazhyn', 0. Paskonkina'. ' E  I .  Gaaz Regional 
HospifaI, 8. -Petmsburg, Russia, zSci. Research Group "MZnt", 
St.-Petenbuz, Russia 
Objectives: It is still little known about features of epidemic process 
of viral hepatitis as well as clinical course of diseases in the subpop- 
ulation of prisoners of Russia and former USSR. This study has 
become possible due to the democratic process in Russia. 
Methods: 368 if prisoners suEered fiom wal hepatitis were 
treated at a special hospital in 1994-1996. Routine biochemical and 
laboratory tests, instrumental and physical examinations, detecting of 
HBV, HCV and HAV markers in ELISA, RIBA and PCR were con- 
ducted. The mean age of patients was 22.1 years, the mean length 
of imprisonment-16.3 months. In 17.7% of patients the summary 
level of serum proteins was less then 65.0 g/l. The 32.2% of pa- 
tients were intravenous drug abusers. The 51.0% of patients with 
viral hepatitis had additional infections or infestations (such as sca- 
bies, streptodermia, tuberculosis, lues, dysentery, yersiniosis, AIDS 
ect.). There were 20.0% of intravenous drug abusers in the group 
of patients with hepatitis A, 25.0% among patients with hepatitis B, 
31.6% among patients with hepatitis C and 75.0% among patients 
with multiple viral hepatitis. 
Results: The HCV, HBV and HAV serological markers were 
detected in 35.6%, 34.8%. 10.8% of patients with viral hepatitis re- 
spectively. The multiple viral hepatitis were obtained in 7.9%. The 
fuirmnant hepatitis was caused by delta-agent superinfection or by 
mixed viral hepatitis followed bacterial-parasitic infection. The dis- 
ease course and some of biochemical tests were not typical as well 
as symptoms of prodromal period. The increasing uend in HCV 
markers was obtained in the last three years. 
Conclusions: The stress, alimentary dystrophy, drug abusing in 
prisoners lead to unusual course of the viral  hepatitis. 
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Prevalence of Anti-HEV Antibodies in 
Hemophilicacs Patients 
E Mesa, A. Guerra-Neira, P. Campo, S. Cmchaga, 
R. Martinez-Zapico. o p t .  ojMicrobiology, La Paz Hospital, Madrid, 
Spain 
Objectives: At the present time, with the testing of all donated 
blood and source plasma for hepatitis B virus (HBV), hepatitis C 
virus (HCV) and human immunodeficiency virus (HIV), the trans- 
mission of these viruses by blood or blood products is now rare. In 
conmt  to HBV and HCV, there are only a few accounts of t r a n s -  
mission of hepatitis E virus (HEV) and hepatitis A virus (HAV) by 
blood transfusion. The aim of the study is to know the prevalence of 
antibodies to HEV in a high risk group U e  hemophilicacs. 
Methods: We tested 90 serum samples kom hemophilicacs pa- 
tients by enzyme immunoassay for IgG anti-HAV and anti HBc 
(Sorin Biomedica), IgG anti-HEV (Abbott), anti-HCV (Sanofi Pas- 
teur), and anti-HIV (Behring). 
Results: The results are shown in the table 
n (%) 
IgGann-HAV 42 (46.6%) 
Anti-HCV 35 (38.8%) 
Anti-HBc 7 (8.1%) 
Ann-HIV 14 (15.5%) 
IKGmti-HEV 4 (4.4%) 
Conclusions: The prevalence of serum antibodies to HEV in 
hemophilicacs (4.4%) is similar to healthy adults (4%) in Spain. These 
data suggest that there is not evidence of parented transmission of 
HEY 
I P978 I Evolution of "Quasispecies" of Woodchuck 
Hepatitis B Virus During the Early Phases of 
Experimental Infection 
C. Argentini, V. La Sorsa, E. D'Ugo, R. Bruni, R. Giuseppetti, 
M. Rapicetta. Lab. of Krology, Ish'tuto Superiore di Sanitd, Rome, Italy 
Objectives: Aim of the work was to characterize the "quasispecies" 
nature of WHV (animal model of hepatitis B virus), and to study its 
evolution during the early phases of the mfection. 
Methods: Serum samples from an experimentally dected wood- 
chuck were collected weekly during the first 3 months of the in- 
fection. Clones (T-vector method) of amplified (nt 2490-419) PreS 
regions of WHV genome were sequenced (37313 ABI automatic se- 
quencer). Phylogenetic analysis was performed using the GCG and 
PHYLIP packages. 
Results: The viral "quasispecies" was present, at the beginning of 
the infection, as well defined variants related but clearly distinguish- 
able from the inoculum (derived from WHV7) variants. The popu- 
lations found in the sera collected 45 and 52 days post mfection are 
homogeneous and highly related to the prototype WHW. In con- 
trast those found 30 and 67 days post-inoculum are heterogeneous 
and less related to WHW. In the serum of 30 days post-inoculum 
sequences of 50% of the clones c o w  for a truncated presl-pres2 
protein. Heterogeneity of truncated mutants was found in the other 
follow up sera. 
Conclusions: The Merences of the "quasispecies" viral popda- 
tion in follow-up sera have shown that the evolution is very dynamic, 
&o during short time intervals with a fast adaptation of WHV in 
response to the environment (the host) changes. The truncated pre-S 
mutants can be involved in the establishment of the chronic infec- 
tion. 
SeNm Thymidine Kinase Levels in Patients with 
Acute Viral Hepatitis A and 6 
M. Siinbiil, A. Be&, C. Erogu, 2. Akpm, B. Adam, H. Ozdener, 
H. Leblebiciogu. Ondokuz Mayis University, Medical School, Samsun, 
Turkiye 
Objective: To evaluate the clinical applications of serum thymidine 
hnase (TK) activity in acute viral hepatitis 
Methods: We compared the TK levels with liver function tests 
such as aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), gamma glutamyl transpeptidase (GGT), alkaline fosfatase in 
50 patients with acute viral hepatitis (29 with type B and 21 with 
type A) and in 22 normal controls. During the acute stage of the 
viral hepatitis, serum TK activity increased significantly in both types 
of hepatitis compared with control (p < 0.0001) and also serum 
TK levels in hepatitis A (16.05 f 15.08 IU/l) (mean f SD) were 
higher than those in hepatitis B (12.61 f 19.04 IU/l) (p < 0.05). 
No significant correlation was observed between serum TK activity 
and finding for AST, ALT, GGT, total and direct bilirubin, serum 
albumin, and globulin in patients with hepatitis A. However, TK 
was correlated with the activity of ALP (rs = 0.59, p < 0.005). As 
to hepatitis B, the only correlation was found between TK and total 
b h b i n  level (r, = -0.39, p < 0.05). 
Conclusion: Our data suggest that a marked elevation of serum 
TK activity may provide a marker for acute wal hepatitis, especially 
type A. 
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Objectives: To evaluate the COBAS Ah4PLICOR PCR system 
(Roche Diagnostic Systems) for detection ofhepatitis C virus (HCV) 
RNA in serum samples. The manual Roche AMPLICOR microwell 
plate HCV Test was the reference method. 
Methods: A total of 245 serum samples, 54 previously deter- 
mined as HCV RNA negative (all anti-HCV positive), and 191 
HCV RNA positive samples were included in the study. Among 
HCV RNA positive samples, 14 samples had bellow 2.000 copies 
of HCV RNNml, 18 samples between 2.000-15.000, 15 samples 
between 15.00G50.000, 28 samples between 50.000-100.000, and 
116 samples more than 100.000 copies of HCV RNA/ml, as deter- 
mined by AMPLICOR HCV Monitor assay. Using Inno LiPa HCV 
I1 assay, HCV RNA was typed in 94 samples as HCV subtype 1 b, in 
44 as genotype 3, in 36 as subtype l a ,  in 11 as subtype 2c, in five as 
subtype Zb, and in one sample as genotype 4. 
Results: For 245 samples tested, there was 100% concordance 
between the results of the manual AMPLICOR PCR system and 
the automated COBAS AMPLICOR system. 
Conclusion: The automated COBAS AMPLICOR system pro- 
vide the &cal microbiology laboratory with specific and sensitive 
PCR method for rapid and reliable detection of HCV RNA. 
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